Item 5.07. Submission of Matters to a Vote of Security Holders.
On June 27, 2019, at the 2019 Annual Meeting of Stockholders (the "Annual Meeting") of Caladrius Biosciences, Inc. (the "Company"), the stockholders voted on and approved the five proposals listed below. The following is a brief description of each matter voted upon at the Annual Meeting (for a full description of each such matter see the Company's definitive proxy statement on Schedule 14A, filed with the Securities and Exchange Commission on April 30, 2019 (the "Proxy Statement")), as well as the final voting results with respect to each such matter:
Proposal 1
. The stockholders re-elected Steven M. Klosk and Steven S. Myers as Class III directors until the annual meeting to be held in 2022. The final voting results with respect to Steven M. Klosk were as follows: 4,325,464 votes for; 24,813 votes against; 14,295 votes abstaining and 3,820,338 broker non-votes. The final voting results with respect to Steven S. Myers were as follows: 4,208,521 votes for; 141,812 votes against; 14,239 votes abstaining and 3,820,338 broker non-votes.
Proposal 2.
The stockholders ratified the appointment of Grant Thornton LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2019. The final voting results with respect to this Proposal were as follows: 7,921,429 votes for; 139,490 votes against; 123,991 votes abstaining and no broker non-votes.
Proposal 3.
The stockholders approved, on a non-binding advisory basis, the executive compensation of the Company's named executive officers as described in the Proxy Statement. The final voting results with respect to this Proposal were as follows: 4,230,771 votes for; 115,280 votes against; 18,521 votes abstaining and 3,820,338 broker non-votes.
Proposal 4.
The stockholders approved, on a non-binding advisory basis, one (1) year as the frequency for holding stockholder advisory votes on the executive compensation of the Company's named executive officers as described in the Proxy Statement. The final voting results with respect to this Proposal were as follows: 4,210,256 votes for one year; 42,690 votes for two years; 98,988 votes for three years; 12,638 votes abstaining and 3,820,338 broker non-votes.
Proposal 5.
The stockholders approved an adjournment or postponement of the Annual Meeting, if necessary, if there were not sufficient votes to provide a quorum. The final voting results with respect to this Proposal were as follows: 7,527,472 votes for; 610,361 votes against; 47,077 votes abstaining and no broker non-votes.
_______________